Phase
Condition
Atrial Fibrillation
Chest Pain
Arrhythmia
Treatment
N/AClinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with documented persistent Atrial Fibrillation lasting longer than 6 monthsdocumented by 24h holter monitoring
Age between 18 and 75 years
Efficient oral anticoagulation during at least 1 month before the procedure
Social security affiliation
Feasible patient follow-up
Patient willing to comply with study requirements and give informed consent toparticipate in this clinical study
Indication for Pulmonary Vein isolation
Exclusion
Exclusion Criteria:
Previous atrial fibrillation ablation
Previous left atrial ablation or surgery
Atrial fibrillation without spontaneous RR interval > 1000ms and with LVEF < 35% (measured by TTE)
Presence of a mechanical mitral valve
Current intracardiac thrombus
Any condition contraindicating chronic anticoagulation
Uncontrolled hyperthyroidism
Anteroposterior LA diameter > 55 mm measured by TTE
Body mass index ≥ 40 kg/m2
Study Design
Connect with a study center
Caen University Hospital
Caen,
FranceSite Not Available
Dieppe Hospital
Dieppe,
FranceSite Not Available
Groupe Hospitalier du Havre
Le Havre,
FranceSite Not Available
Rouen University Hospital
Rouen,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.